Therapeutic Opportunities for Dry Powder Inhalation Accelerating
Greystone Associates Analyzes Technology and Therapeutic Factors
(Amherst, NH) – The convergence of socioeconomic and technology factors – the growing emphasis on drug self-administration for chronic conditions, the expected acceleration in protein- and peptide-based therapeutics, the availability of innovative inhaler device designs - is driving interest in pulmonary drug delivery technology and devices as an alternative to oral and parenteral routes of administration. While several approaches for delivering active substances to, and systematically via, the lungs compete in this space, a new survey reveals the emerging developments and market dynamics that have positioned dry powder inhalation as the technology of choice for an increasing number of therapeutic drugs.
The survey concludes that the rising potential of dry powder inhalation is being driven by escalating research activity in powder formulations, advances in particle engineering, and the development of novel device architectures. “The combination of improved particle properties and more efficient inhaler designs is creating new opportunities for dry powder inhalation and expanding the range of active compounds that can be effectively delivered via the lung”, explains George Perros, Greystone’s Managing Director. “We believe dry powder inhalation will become a major factor in the delivery of a number of emerging therapeutics.”
These findings are contained in a new and comprehensive report: Dry Powder Inhalation: Drugs, Devices, And Delivery Therapeutics. It includes comprehensive assessments of dry powder inhalation technology, profiles of dry powder inhalation market participants, industry data and forecasts, and detailed analysis of design and economic factors.
More information is available at www.greystoneassociates.org .
About Greystone
Greystone Associates is a medical and healthcare technology consulting firm providing services in strategic planning, venture development, product commercialization, and technology and market assessment.
Contact:
Mark Smith
Voice: 603-595-4340
Fax: 603-804-0466
www.greystoneassociates.org Source: Greystone Associates
